Methods and compositions for the production of adenoviral vectors

Details for Australian Patent Application No. 2004241421 (hide)

Owner Introgen Therapeutics, Inc.

Inventors Zhang, Shuyuan; Pham, Hai

Agent Pizzeys

Pub. Number AU-A-2004241421

PCT Pub. Number WO2004/104190

Priority 10/439,278 15.05.03 US

Filing date 14 May 2004

Wipo publication date 2 December 2004

International Classifications

C12N 7/02 (2006.01) Viruses, e.g. bacteriophages - Recovery or purification

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2004/104190 Priority application(s): WO2004/104190

26 November 2009 Assignment before Grant

  Introgen Therapeutics, Inc. The application has been assigned to Crucell Holland B.V.

10 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004241436-RANBP2 as modifier of the PTEN/IGF pathway and methods of use

2004241420-In-cylinder combustion recipe for meeting Tier 2 locomotive emissions regulations